Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: January 2022
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 9 of 9 items.
Reddy-Dasatinib: out of specification
RecallHealth product recall | 2022-01-31
APO-AMITRIPTYLINE 10mg: NDMA impurity
RecallHealth product recall | 2022-01-26
ELAVIL 10mg: NDMA impurity
RecallHealth product recall | 2022-01-26
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17
Piperacillin and Tazobactam for injection: Particulate
RecallHealth product recall | 2022-01-17
XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
AlertHealth professional risk communication | 2022-01-12
Shelf Life Extension for the SPIKEVAX (elasomeran) COVID-19 Vaccine with Printed Expiry Dates on Vial and Carton Labels
AlertHealth professional risk communication | 2022-01-11
Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
AlertHealth professional risk communication | 2022-01-07